|
|
|
|
Whether you are planning a first overseas study or expanding an established pipeline, gain strategic insights to help navigate complexities, maximize investment, and position new therapies for international success. Explore going global independently, licensing out, and collaborating with multinational corporations.
|
|
|
|
|
The shifting regulatory landscape requires a smarter approach. Learn how to adapt to new regulatory initiatives, prioritize markets, and build flexibility into your programs for faster market entry and success. Review how early-stage sponsors can adapt to these changes, including new FDA initiatives such as AI-driven reviews and user fee changes.
|
|
|
|
|
This year’s European Society for Medical Oncology (ESMO) Congress drew more than 37,000 participants for five days of rich data, discussion, and debate. The meeting showcased the rapid evolution of cancer care, with precision oncology, next-generation immunotherapies, and meaningful, patient-centered endpoints taking center stage.
|
|
|
|
|
New Zealand is gaining global recognition as a high-quality, cost-efficient hub for early-phase and innovative clinical research. With regulatory agility, experienced investigators, and a collaborative healthcare ecosystem, sponsors can achieve quicker first-patient-in milestones and a faster path to proof-of-concept for their development programs.
|
|
|
|
|
|
|
Stay ahead of the evolving oncology clinical trial landscape. Gain strategic insights to optimize study design, site selection, and patient recruitment for successful early-phase development programs.
|
|
|
